US2014186887A1PendingUtilityA1

RECEPTOR ACTIVATOR OF NF-kappaB

69
Assignee: IMMUNEX CORPPriority: Dec 23, 1996Filed: Oct 28, 2013Published: Jul 3, 2014
Est. expiryDec 23, 2016(expired)· nominal 20-yr term from priority
A61P 35/00A61P 37/02A61P 43/00A61P 37/00C07K 14/7151C07K 2317/73C07K 14/70575A61P 29/00C07K 16/241C07K 2319/00C07K 2317/76A61K 38/00C07K 16/2875C07K 2319/32C07K 2319/73C07K 14/435C12Q 1/6876C07K 2319/02C07K 14/70578C07K 14/525C07K 2319/30C07K 14/52
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . An isolated DNA encoding a polypeptide comprising the amino acid sequence of amino acids 33 through 196 of SEQ ID NO:6 or a fragment thereof, wherein the polypeptide or fragment can bind a RANKL polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:13. 
     
     
         2 . An isolated DNA encoding a RANK polypeptide, wherein the amino acid sequence of the polypeptide is at least 80% identical to the amino acid sequence as set forth in SEQ ID NO:6, and wherein the RANK polypeptide can bind a RANKL polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:13. 
     
     
         3 . A vector comprising the DNA of  claim 1 . 
     
     
         4 . A vector comprising the DNA of  claim 2 . 
     
     
         5 . A host cell comprising the vector of  claim 3 . 
     
     
         6 . A host cell comprising the vector of  claim 4 . 
     
     
         7 . A process for preparing a polypeptide comprising culturing the host cell of  claim 5  under conditions promoting expression of the polypeptide. 
     
     
         8 . A process for preparing a polypeptide comprising culturing the host cell of  claim 6  under conditions promoting expression of the polypeptide.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.